Headquarters
4640 S MACADAM AVE STE 200, PORTLAND, OR 97239-4232, US
PORTLAND, OR, US
GAMMA THERAPEUTICS INC
From the company
Gamma Diagnostics is the global expert in Gamma Prime Fibrinogen (GPF), a biomarker for predicting clotting and inflammation in cardiovascular disease and other conditions such as COVID-19. Founder Dr. David Farrell and his team discovered GPF in 2010. The company offers the GammaCoeur CVD Risk ELISA Test System, a semi-automated quantitative ELISA method for detecting and assessing GPF in human venous plasma samples for clinical and research laboratories.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.